These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 2959641

  • 1. Reversibility of long-term effects of GnRH agonist administration on testicular histology and sperm production in the nonhuman primate.
    Weinbauer GF, Respondek M, Themann H, Nieschlag E.
    J Androl; 1987; 8(5):319-29. PubMed ID: 2959641
    [Abstract] [Full Text] [Related]

  • 2. Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis).
    Weinbauer GF, Surmann FJ, Akhtar FB, Shah GV, Vickery BH, Nieschlag E.
    Fertil Steril; 1984 Dec; 42(6):906-14. PubMed ID: 6389185
    [Abstract] [Full Text] [Related]

  • 3. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
    Mann DR, Gould KG, Smith MM, Duffey T, Collins DC.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
    [Abstract] [Full Text] [Related]

  • 4. Suppression of spermatogenesis in a nonhuman primate (Macaca fascicularis) by concomitant gonadotropin-releasing hormone antagonist and testosterone treatment.
    Weinbauer GF, Surmann FJ, Nieschlag E.
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):138-46. PubMed ID: 3544633
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Time course of recovery of spermatogenesis and Leydig cell function after cessation of gonadotropin-releasing hormone antagonist treatment in the adult rat.
    Hikim AP, Swerdloff RS.
    Endocrinology; 1994 Apr; 134(4):1627-34. PubMed ID: 8137724
    [Abstract] [Full Text] [Related]

  • 11. Effects of an LHRH agonist analog upon sexual function in male dogs. Suppression, reversibility, and effect of testosterone replacement.
    Vickery BH, McRae GI, Briones W, Worden A, Seidenberg R, Schanbacher BD, Falvo R.
    J Androl; 1984 Apr; 5(1):28-42. PubMed ID: 6231277
    [Abstract] [Full Text] [Related]

  • 12. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
    Pogach LM, Lee Y, Gould S, Giglio W, Huang HF.
    Cancer Res; 1988 Aug 01; 48(15):4354-60. PubMed ID: 3134124
    [Abstract] [Full Text] [Related]

  • 13. Influence of continuous gonadotropin-releasing hormone (GnRH) agonist treatment on luteinizing hormone and testosterone secretion, the response to GnRH, and the testicular response to human chorionic gonadotropin in male rhesus monkeys.
    Mann DR, Gould KG, Collins DC.
    J Clin Endocrinol Metab; 1984 Feb 01; 58(2):262-7. PubMed ID: 6363435
    [Abstract] [Full Text] [Related]

  • 14. GnRH agonists and antagonists stimulate recovery of fertility in irradiated LBNF1 rats.
    Meistrich ML, Wilson G, Shuttlesworth G, Huhtaniemi I, Reissmann T.
    J Androl; 2001 Feb 01; 22(5):809-17. PubMed ID: 11545294
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
    Ward JA, Robinson J, Furr BJ, Shalet SM, Morris ID.
    Cancer Res; 1990 Feb 01; 50(3):568-74. PubMed ID: 2137024
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L, Bhasin S, Salameh W, Steiner B, Peterson M, Sokol RZ, Rivier J, Vale W, Swerdloff RS.
    J Clin Endocrinol Metab; 1992 Aug 01; 75(2):476-83. PubMed ID: 1639948
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.